Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Inhibition of Osteoclast Differentiation by Tanshinones from the Root of Salvia miltiorrhiza Bunge

  • Published : 2005.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

We screened natural products to find compounds with anti-osteoporotic potential using a coculture-based system by which osteoclast differentiation is effectively achieved. We found that methylene chloride soluble fraction of the root of Salvia miltiorrhiza Bunge (Labiatae) suppressed osteoclast differentiation. Five tanshinones, tanshinone IIA (1), tanshinone I (2), cryptotanshinone (3), 15,16-dihydrotanshinone I (4), and ferruginol (5) were subsequently isolated from fraction. Among the five compounds, compounds 1-4 reduced the formation of TRAP­positive multinuclear osteoclasts. These results suggest that the identified tanshinones may be useful candidates for development of therapeutic agents to treat osteoporosis and other bone-resorptive diseases.

Keywords

References

  1. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., and Galibert, L. A., Homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature, 390, 175-195 (1997) https://doi.org/10.1038/36593
  2. Harrison, L. J. and Asakawa, Y., 18-Oxoferruginol from the leaf of Torreya nucifera. Phytochemistry, 26, 1211-1212 (1987) https://doi.org/10.1016/S0031-9422(00)82385-7
  3. Lacey, D. L., Tan, H. L., Lu, J., Kaufman, S., Van, G., Qiu, W., Rattan, A., Scully, S., Fletcher, F., Juan, T., Kelley, M., Burgess, T. L., Boyle, W. J., and Polverino, A. J., Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am. J. Pathol., 157, 435-48 (2000) https://doi.org/10.1016/S0002-9440(10)64556-7
  4. Lee, Z. H. and Kim, H. H., Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun., 305, 211-214 (2003) https://doi.org/10.1016/S0006-291X(03)00695-8
  5. Lee, S. E., Woo, K. M., Kim, S. Y., Kim, H. M., Kwack, K., Lee, Z. H., and Kim, H. H., The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone, 30, 71-77 (2002)
  6. Lee, S. E., Chung, W. J., Kwack, H. B., Chung, C. H., Kwack, K., Lee, Z. H., and Kim, H. H., Tumor necrosis factor-${\alpha}$ supports the survival of osteoclasts through the activation of Akt and ERK. J. Biol. Chem., 276, 49343-49349 (2001) https://doi.org/10.1074/jbc.M103642200
  7. Miyamoto, T., Arai, F., Ohneda, O., Takagi, K., Anderson, D. M., and Suda, T., An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand. Blood, 96, 4335-4343 (2000)
  8. Mundy, G., Bone remodeling, In Favus, M. J. (Eds). Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams & Wilkins, Philadelphia, pp. 30-38 (1999)
  9. Ryu, S. Y., No, Z. S., Kim, S. H., and Ahn, J. W., Two novel abietane diterpenes from Salvia miltorrhiza. Planta Med., 63, 44-46 (1997) https://doi.org/10.1055/s-2006-957601
  10. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., and Martin, T. J., Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev., 20, 345-357 (1999) https://doi.org/10.1210/er.20.3.345
  11. Takeshita, S., Kaji, K., and Kudo, A., Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res., 15, 1477-1488 (2000) https://doi.org/10.1359/jbmr.2000.15.8.1477
  12. Tang, W. and Eisenbrand, G., Chinese drugs of plant origin, Berlin, Springer-Verlag, (1992)
  13. Tezuka, Y., Kasimu, R., Basnet, P., Namba, T., and Kadota S., Aldose reductase inhibitory constituents of the root of Salvia miltiorhiza BUNGE. Chem. Pharm. Bull., 45, 1306-1311 (1997) https://doi.org/10.1248/cpb.45.1306
  14. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S. I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahash, N., and Suda, T., Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and identical to TRANCE-RANKL. Proc. Natl. Acad. Sci. U.S.A., 95, 3579-3602 (1998) https://doi.org/10.1073/pnas.95.7.3597